These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9075574)

  • 21. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome.
    Monteagudo J; Pereira A; Roig S; Reverter JC; Ordinas A; Castillo R
    Am J Hematol; 1990 Jan; 33(1):46-9. PubMed ID: 2104558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies.
    Hornsey V; Micklem LR; McCann MC; James K; Dawes J; McClelland DB; Prowse CV
    Thromb Haemost; 1985 Aug; 54(2):510-4. PubMed ID: 3878608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ristocetin-induced platelet agglutination stimulates GPIIb/IIIa-dependent calcium influx.
    Bertolino G; Noris P; Spedini P; Balduini CL
    Thromb Haemost; 1995 Apr; 73(4):689-92. PubMed ID: 7495080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in intracellular calcium ions during shear induced platelet aggregation.
    Kawakami K; Fukuyama M; Sakai K; Itagaki I; Kawano K; Handa M; Ikeda Y
    ASAIO Trans; 1990; 36(3):M696-9. PubMed ID: 2252786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shear stress-induced binding of von Willebrand factor to platelets.
    Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
    Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagen.
    Houdijk WP; Girma JP; van Mourik JA; Sixma JJ; Meyer D
    Thromb Haemost; 1986 Dec; 56(3):391-6. PubMed ID: 3551182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ristocetin induced platelet aggregation in children with nephrotic syndrome].
    Taira K; Okajima C; Yamashita T; Kawahara S; Matsunaga T; Nakajima M; Kamitsuji H
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):659-66. PubMed ID: 2214316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
    Sobel M; McNeill PM; Carlson PL; Kermode JC; Adelman B; Conroy R; Marques D
    J Clin Invest; 1991 May; 87(5):1787-93. PubMed ID: 2022745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased aggregation and secretion responses of human platelets when loaded with the calcium fluorescent probes quin2 and fura-2.
    Lanza F; Beretz A; Kubina M; Cazenave JP
    Thromb Haemost; 1987 Aug; 58(2):737-43. PubMed ID: 3672425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.